bioAffinity Technologies, Inc. Quarterly Revenues in USD from Q3 2022 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
bioAffinity Technologies, Inc. annual/quarterly Revenues history and growth rate from Q3 2022 to Q3 2023.
  • bioAffinity Technologies, Inc. Revenues for the quarter ending September 30, 2023 was $300K.
  • bioAffinity Technologies, Inc. annual Revenues for 2023 was $7.9M, a 14.5% increase from 2022.
Revenues, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $300K +$299K Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q1 2023 $1.81M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q3 2022 $1.15K* Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.